Clinical efficacy of sequential lateral decubitus in patients with moderate Corona virus disease 2019

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300069924

Enrollment

Unknown

Registered

2023-03-29

Start date

2023-04-01

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corona virus disease 2019

Interventions

experimental group:Sequential lateral positioning

control group:Awake prone positioning

Eligibility

Sex/Gender

All

Age

18 Years to 96 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis of medium novel coronavirus infection, diagnostic criteria and clinical classification refer to the Diagnosis and Treatment Protocol for Novel Coronavirus Infection (Trial 10th Edition); 2. SpO2 22 times /min without respiratory support; 3. > 18 years old; 4. Conscious, informed consent and cooperation.

Exclusion criteria

Exclusion criteria: 1. is at risk of airway obstruction, asphyxia, respiratory failure and requires or has been intubated; 2. End-stage comorbidity, multiple organ failure; 3. Install cardiac pacemaker or heart stent; 4. Cervical spine, spine disease or fracture; 5. Recent abdominal surgery or intra-abdominal hypertension; 6. Acute hemorrhagic disease; Skin damage or skin damage; 7. Pregnant women.

Design outcomes

Primary

Measure	Time frame
SaO2;PaO2/FiO2;	—

Secondary

Measure	Time frame
Complications;Respiratory outcome;Borg Score;Comfort score;	—

Countries

china

Contacts

Public ContactYun Ye

Zhenjiang Third Hospital Affiliated to Jiangsu University

jszjsyyy@163.com+86 135 1169 7088

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026